ANTIDote was succesfully represented at The Workshop on Arthropod-Borne Diseases transmitted by ticks, mites, fleas, and lice, Friedrich-Loeffler Institute, Insel Riems, Germany, 15th-16th November 2018
ANTIDote was succesfully represented at ICLB, Atlanta, Georgia, USA, 11-14 September 2018
ANTIDote was succesfully represented at the GRC Biology of Spirochetes 2018 (Ventura, USA)
ANTIDote was succesfully represented at the First Joint Conference of the Association of Institutions of Tropical Veterinary Medicine (AITVM) and the Society for Tropical Veterinary Medicine (STVM), Berlin, Germany, 4-8 September 2016
ANTIDote was succesfully represented at the Gordon Research Conference Biology of Spirochetes in Ventura, January 10th – 15th 2016.
ANTIDote was succesfully represented at the World Veterinary Vaccine Congress 2015, Madrid Spain, November 9th – 11th 2015.
ANTIDote was succesfully represented at the International Conference on Lyme borrreliosis and other tick-borne diseases (ICLB) 2015, Vienna, Austria, September 27 th-30th 2015
TTP8 & STVM12 conference in Cape Town
24-29 august 2014
ANTIDotE was succesfully represented at the TTP8 & STVM12 conference in Cape Town 24-29 August 2014 by Ard Nijhof (FUB), Petr Kopacek (BC ASCR) and Jos Trentelman (AMC).
Targeting the tick
24 February 2014 , by Gary Finnegan
Understanding the bloodsucking feeding mechanisms of ticks could result in vaccines against hard-to-treat diseases like Lyme disease.
A sneeze, a cough, a kiss – even a handshake: diseases such as measles, whooping cough and the flu are often passed directly from one person to another in tiny droplets of fluid which contain viruses or bacteria. However, not all infectious diseases are spread so directly. Some hijack bloodthirsty insects and arachnids, taking the opportunity to infect humans during feeding time. One such disease risk is the humble tick – an eight-legged parasite often found in Europe’s forests.
Three million Euro’s for a vaccine against ticks
Amsterdam, August 12th 2013
The AMC, in collaboration with six European partners, will investigate a vaccine against ticks. This vaccine has to prevent multiple tick-borne diseases. The three million Euro’s, funded by the European Commission as part of the FP7 Work Program, will be divided over the consortium.